Drug-induced hyperkalemia

Hospital Pharmacy

Volumn 31, Issue 3, 1996, Pages 221-228

  Tolstoi, Linda G ^a  

^a NONE   (United States)

Author keywords

diagnosis; drug induced hyperkalemia; pharmacist's role; treatment

Indexed keywords

ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIGITALIS GLYCOSIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; OCTREOTIDE; PENICILLIN G POTASSIUM; POTASSIUM CHLORIDE; POTASSIUM ION; POTASSIUM SPARING DIURETIC AGENT; PROPRANOLOL; TRIMETHOPRIM;

DRUG FORMULATION; DRUG INDUCED DISEASE; FOOD DRUG INTERACTION; HUMAN; HYPERKALEMIA; INTRACELLULAR FLUID; PATIENT COUNSELING; POTASSIUM BALANCE; POTASSIUM BLOOD LEVEL; REVIEW;

EID: 0029929403     PISSN: 00185787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Cannon-Babb ML, Schwartz AB. Drug-induced hyperkalemia Hosp Pract 1986; 21:99-127.
2. Gill JR Jr, Santos F, Chan JCM. In: Chan JCM, Gill JR Jr., eds. Kidney Electrolyte Disorders. New York: Churchill Livingstone, 1990
3. Kleinfeld M, Corcoran AJ. Hyperkalemia in the elderly. Comp Ther 1990; 16.49-53.
4. Defronzo RA Hyperkalemic states. In: Maxwell MH, Kleenman CR, Narins RG, eds. Clinical Disorders of Fluid and Electrolyte Metabolism. New York: McGraw Hill Book. 1986.
5. Pelter MA. Electrolyte and other minerals. In. Traub SL, ed. Basic Skills in Interpreting Laboratory Data. Bethesda: American Society of Hospital Pharmacists, 1992.
6. Mudge GH, Weiner IM Agents affecting volume and composition of body fluids In: Goodman AG, Rall TW, Nies AS, Palmer P, eds The Pharmacological Basis of Therapeutics. New York: Pergamon Press, 1990.
7. Williams ME, Rosa RM, Epstein FH. Hyperkalemia. Adv Int Med 1986; 31:265-291.
8. Martin ML, Hamilton R, West MF. Potassium Emer Med Clin North Am 1986; 4:131-144.
9. Williams AV. Hyperkalemia: Mechanisms, etiology, and treatment J S C Med Assoc 1992; 88:561-565.
10. Cohen JJ. Disorders of potassium balance. Hosp Pract 1979; 14:119-128.
11. McSweeney GW. Fluid and electrolyte therapy and acid-base balance. In: Herfindal ET, Gourley DR, Hart LL. eds. Clinical Pharmacy and Therapeutics. Baltimore: Williams and Wilkins, 1992
12. McMahon FG. Potassium-sparing diuretics and potassium supplements. In: Management of Essential Hypertension The Once-A-Day-Era. Mt. Kisco: Futura Publishing, 1990
13. Saxena K. Death from potassium chloride overdose Postgrad Med 1988; 84:97-102.
14. Olin BR, ed. Salt substitute product table. In: Facts and Comparisons. St. Louis: JB Lippincott, 1989.
15. Yap V, Patel A, Thomsen J. Hyperkalemia with cardiac arrhythmia J Amer Med Assoc 1976, 236-2775-76.
16. Hoyt RE Hyperkalemia due to salt substitutes. J Amer Med Assoc 1986; 256:1726.
17. Riccardella D, Dwyer J. Salt substitutes and medicinal potassium sources: Risks and benefits. JADA 1985; 85.471-474.
18. McCaughan D. Hazards of non-prescription potassium supplements Lancet 1984; 1:513-14.
19. Sopko JA, Freeman RM Salt substitutes as a source of potassium. J Amer Med Assoc 1977; 238:608-10.
20. Stolz ML, Andrew CE Jr. Severe hyperkalemia during very-low calorie diets and angiotensin-converting enzyme use. J Amer Med Assoc 1990; 264:2737-38.
21. Olin BR, ed. Enteral Nutritional Therapy. In: Facts and Comparisons. St. Louis: JB Lippincott, 1991.
22. Olin BR, ed. Penicillins In: Facts and Comparisons, St. Louis: JB Lippincott, 1991.
23. Mercer CW, Logic JR Cardiac arrest due to hyperkalemia following intravenous penicillin administration. Chest 1973; 64: 358-59
24. Melby JC. The renin-angiotensin-aldosterone complex. Amer J Med 1986; 81(Suppl):8-12.
25. Textor SC, Brave EL, Fouad M, et al. Hyperkalemia in azotemia patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril. Amer J Med 1982; 73:719-25.
26. Sakemi T, Ohchio N, Sanai T, et al. Captopril-induced metabolic acidosis with hyperkalemia. Am J Nephrol 1988; 8:245-48
27. Doman K, Perlmutter JA, Muhammedi M, et al. Life-threatening hyperkalemia associated with captopril administration. South Med J 1993; 86.1269-72.
28. Lamy PP. Renal effects of nonsteroidal anti-inflammatory drugs. J Am Geriatr Soc 1986; 34:361-67.
29. Hochberg MC. NSAIDS: Patterns of usage and side effects. Hosp Pract 1989; 24: 161-74.
30. Sager DS, Bennett RW. Individualizing the risk/benefit ratio of NSAIDs in older patients. Geriatrics 1992; 47:24-31
31. Tan SY, Shapiro R, Franco R, et al. Indomethacin-induced prostaglandin inhibition with hyperkalemia. Ann Intern Med 1979; 90:783-85.
32. Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal anti-inflammatory drugs. N Engl J Med 1984; 310:563-72.
33. Galler M, Folkert WC, Schlondorff D Reversible acute renal insufficiency and hyperkalemia following indomethacin therapy. JAMA 1981; 246.154-55.
34. Steinmetz PR, Koeppen BM. Cellular mechanisms of diuretic action along the nephron Hosp Pract 1984; 19:125-34.
35. Greenberg A. What's new in diuretic therapy. Am Fam Phys 1986, 33:200-12
36. Gonzalez-Martin G, Diaz-Molinas MS, Martinez AM, et al. Herpain-induced hyperkalemia A prospective study. Int J Clin Pharraacol Ther Tox 1991; 29:446-50.
37. O'Kelly R, Magee F, McKenna TJ. Routine heparin therapy inhibits adrenal aldosterone production. J Clin Endo Metab 1983; 56:108-12.
38. Conn JW, Rovner DR, Cohen EL, et al. Inhibition of aldosterone biosynthesis in man. J Clin Endocrinol Metab 1966; 26. 527-32
39. Aull J, Chao H, Coy K. Heparin-induced hyperkalemia Ann Pharmacother 1990: 24: 244-46.
40. Perez GO, Lespier L, Knowles R, et al. Potassium homeostasis in chronic diabetes Arch Intern Med 1977; 137:1018-112.
41. Edes TE Hepann-induced hyperkalemia Postgrad Med 1990; 87:104, 106.
42. Choi MC, Fernandez PC, Patnail A, et al Brief report: Trimethoprim-induced hyperkalemia in a patient with AIDS N Engl J Med 1993; 328:703-06.
43. Greenberg S, Reiser IW, Chou SY, et al Trimethoprim-sulfamethoxazole induces reversible hyperkalemia. Ann Intern Med 1993; 119:291-95.
44. Velazquez H, Perazella MA, Wright FS, et al Renal mechanism of trimethoprim-induced hyperkalemia. Ann Intern Med 1993; 119:296-301.
45. Rosa RM, Silva P, Young JB, et al Adrenergic modulation of extrarenal potassium disposal. N Engl J Med 1980; 302:431-34.
46. Brown MJ, Brown C, Murphy MB. Hypokalemia from beta2-receptor stimulation by circulating eptnephrine. N Engl J Med 1983; 309:1414-19
47. Schwartz AB, Cannon-Babb M. Hyperkalemia due to drugs in diabetic patients. Am Fam Phys 1989; 39:225-31.
48. Reza MJ, Kovick RB, Shine KI, et al Massive intravenous digoxin overdose. N Engl J Med 1974; 291:777-78.
49. Sargent AI, Overton CC, Kuwik RJ, et al. Octreotide-induced hyperkalemia. Pharmacotherapy 1994; 14:497-501.
50. Andreoli TE. Disorders of fluid volume, electrolyte, and acid-base balance In Wyngaarden JB. Smith LH Jr, eds. Cecil Textbook of Medicine Philadelphia: WB Saunders, 1985.